Nice to read about the plans to develop 1801 into a specific application. As a shareholder I am reassured. The team have obviously been selecting the best method of proving up our groundbreaking research. Nice to also to see mention of the fda. This has reaffirmed my decision to hold.
Ann: Botanix Update on BTX 1801 Clinical Development, page-13
-
- There are more pages in this discussion • 27 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.5¢ |
Change
0.015(4.55%) |
Mkt cap ! $624.4M | |||
| Open | High | Low | Value | Volume |
| 32.5¢ | 35.0¢ | 32.3¢ | $2.184M | 6.494M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 38963 | 34.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.5¢ | 34769 | 1 |
View Market Depth
| Last trade - 16.10pm 12/08/2024 (20 minute delay) ? |
| BOT (ASX) Chart |